BC
Bio-Techne Corp
🇩🇪XFRA.TE1GermanyHealthcare
€62.14EURup +0.16 (+0.26%)OpenEnd of day7:12 PM
Price€62.14+0.16 (+0.26%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US09073M1045
- CUSIP
- Not reported
Company
- Employees
- 3,000
- Headquarters
- Minneapolis, United States
- Website
- https://www.bio-techne.com
- CEO
- Mr. Kim Kelderman
Market
- Shares outstanding
- 155.8M
- Market cap
- €9.68B
Highlights
- Market cap
- €9.68B
- EPS LTM
- $1.16
- P/E LTM
- 61.08
- Div yield
- 0.45%
Fundamentals (LTM)
- Revenue
- $1.22B-0.38%down year on year
- Net income
- $181.86M+147.77%up year on year
- Gross margin
- 65.77%+1.5%up year on year
- Free cash flow
- $263.22M+2.6%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.